Form 4: Instil Bio Director R Kent Jr McGaughy Acquires 5,000 Stock Options

R Kent Jr McGaughy, a director of Instil Bio, Inc., reported the acquisition of 5,000 stock options on June 13, 2024.

Summary

• On June 13, 2024, R Kent Jr McGaughy, a director of Instil Bio, Inc., acquired 5,000 stock options.
• The exercise price of these options is $10.50.
• The options vest in 12 equal monthly installments starting July 13, 2024, contingent upon continuous service.
• Any unvested portion will fully vest at the next annual stockholder meeting, also subject to continuous service.
• Full vesting also occurs upon death, disability, or a change in control.
• The options expire on June 12, 2034.
• Following the transaction, McGaughy directly owns 5,000 derivative securities.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing. The acquisition of options could be seen as a slightly positive sign, but it's not a major event.

Positives

• The acquisition of stock options by a director may signal confidence in the company's future prospects.

Future Outlook

The vesting schedule indicates a focus on retaining the director's services over the next year, with full vesting possible under certain conditions like death, disability, or a change in control.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates a director's increased stake in the company, which is common.

Stakeholder Impact

• The acquisition of stock options by a director could be viewed positively by shareholders as it aligns the director's interests with those of the shareholders.

Key Dates